The World Drug Safety Congress Europe will bring together 550+ drug safety, pharmacovigilance, data analytics, epidemiology, and other key players in the biopharma sector. Explore the use of big data and AI in pharmacovigilance, examine benefit-risk management strategies and patient-centric approaches; discuss how you can tackle the challenges of social media and drug safety legislation globally. Make sure you are at the heart of the new drug safety era and participate in these critical discussions.
The meeting is set to bridge the gap between international regulatory bodies, industry professionals and academic representatives and will address how to drive pharmacovigilance operations forward.
All companies in the pharma industry have an enormous opportunity to better their drug safety capabilities, technological functions and risk management measures. It is core to ensuring regulatory compliance and establishing a robust PV strategy. It is core to your professional future.
World Drug Safety Europe 2019 offers outstanding opportunities for solutions providers, from senior sponsorship to a range of exhibition booths on a fantastic floor plan. If you are looking to the future of the Pharmacovigilance sector in biopharma industry, then this is your best ROI in 2019.